Physician profile
Todd Allain
NPI 1083633358
$583.64
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.39 · 2020: $215 · 2021: $151 · 2022: $175.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $119.82 | 2019-2021 | |
| Smith+Nephew, INC. | $116.92 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $86.88 | 2022 | |
| Bioventus LLC | $77.14 | 2020 | |
| Kuros Biosciences USA, INC | $71.51 | 2022 | |
| Life Spine, INC. | $42.63 | 2021 | |
| Organogenesis INC. | $30.69 | 2020 | |
| Kerecis Limited | $21.82 | 2021 | |
| Treace Medical Concepts, INC. | $16.23 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Allain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.